1. Home
  2. ASTH vs ANIP Comparison

ASTH vs ANIP Comparison

Compare ASTH & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

N/A

Current Price

$38.17

Market Cap

1.9B

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$74.44

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTH
ANIP
Founded
1994
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
ASTH
ANIP
Price
$38.17
$74.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$34.86
$110.00
AVG Volume (30 Days)
494.0K
342.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
0.69
2.32
Revenue
$519,907,752.00
$206,547,000.00
Revenue This Year
$27.38
$21.01
Revenue Next Year
$10.78
$17.59
P/E Ratio
$57.03
$32.48
Revenue Growth
45.90
2.47
52 Week Low
$18.08
$70.15
52 Week High
$51.60
$99.50

Technical Indicators

Market Signals
Indicator
ASTH
ANIP
Relative Strength Index (RSI) 47.00 39.03
Support Level $35.62 N/A
Resistance Level $40.03 $83.43
Average True Range (ATR) 2.03 2.55
MACD 0.43 -0.13
Stochastic Oscillator 58.76 9.26

Price Performance

Historical Comparison
ASTH
ANIP

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: